|Composition : ||100mg/1ml, 200mg/2 ml|
|Indications:||Premenstrual syndrome, maintenance of pregnancy in case of threatened or habitual abortion, sterlity due to luteal deficiency. In menopause to reduce the risk of endometrial hyperplasia and carcinoma in post menopausal woman receiving conjugated oestrogens. Puerperal depression.|
|Contraindications: ||Hypersensitivity, undiagnosed veginal bleeding, liver dysfunction , cerebral apoplexy, thrombophlebitis, thromboembolic disorders.|
|Safely profile:||Migraine, asthma, esilepsy, renal dysfunction, driving or operating hazardous machinery should be avoided. Diabeted patients receiving oestrogen-prgesterone comination therapy should be monitored.|
|Adverse effects: ||Drowsiness, giddiness, weight gain/loss/rash, diarrhea/menstrual irregulations.|
|Dosage: ||Maintenance of pregnancy in cases of habitual or threatened abortion :200 to 400 mg per day in divided doses.|
For premenstrual syndrome :200-400 mg 1-2 times daily form the 12th to 14th day cycle until onset of menstruation
For puerperal depression : 400mg twice daily In devided doses.
Supplementation of the luteal phase in case of sterility due to luteal deficiency :400 to 600 mg par day up to the 12th week of pregnancy.
|Purity :||Not less than 99%.|